You are here » Home » Companies » Company Overview » Bal Pharma Ltd

Bal Pharma Ltd.

BSE: 524824 Sector: Health care
NSE: BALPHARMA ISIN Code: INE083D01012
BSE 00:00 | 29 Jun 96.55 -2.00
(-2.03%)
OPEN

96.75

HIGH

97.05

LOW

96.20

NSE 00:00 | 29 Jun 96.90 -1.80
(-1.82%)
OPEN

97.80

HIGH

97.90

LOW

95.25

OPEN 96.75
PREVIOUS CLOSE 98.55
VOLUME 2592
52-Week high 148.50
52-Week low 87.50
P/E 17.52
Mkt Cap.(Rs cr) 150
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00
OPEN 96.75
CLOSE 98.55
VOLUME 2592
52-Week high 148.50
52-Week low 87.50
P/E 17.52
Mkt Cap.(Rs cr) 150
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00

Bal Pharma Ltd. (BALPHARMA) - Company History

Bal Pharma (BPL) a member of the Mcro Laboratories group was incorporated as a private limited company in May '87. In Mar.'90 BPL took over a pharmaceutical products manufacturing unit located in Bangalore through the Karnataka State Finance Corporation for a consideration of Rs 25.18 lac following which BPL commenced manufacturing formulations.BPL manufactures and markets pharmaceutical formulations -- paracetamol aluminium hydroxide povidone iodine alprazolam gliclazide griseofulvin lactobacillus rifampicin piroxicam amoxycillin etc. The company promotes its products through the common sales force of the group but proposes to induct its own soon. It came out with a public issue in Feb.'95 for manufacture of bulk drugs and expansion of pharmaceutical formulations.During 1997-98 the formalities of takeover of the unit from Lakme Limited have been completed and effective from 23rd July 1997 the unit has become a division of Bal Pharma Limited. The company's product range has been expanded with the introduction of AZIWIN CAFIMOL & CORTIDERM.The company has added further product range Zanovid Aziwin Dry Syrup Meloxi Ocium - M Progit - MPS in its ethical division during 1999-2000. As part of the expansion of the product range the company has introduced Cardiac Specialities Products. To market these products a new division named SERVETUS has started functioning during 2001. New products like AmilorideBenzydamine and Ebastine were rolled into the market during 2002.

.